L. W. Church to Female
This is a "connection" page, showing publications L. W. Church has written about Female.
Connection Strength
0.020
-
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis. 1997 Apr; 175(4):915-20.
Score: 0.007
-
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet. 2005 Oct 22-28; 366(9495):1435-42.
Score: 0.003
-
Benefits and harms of doxycycline treatment for Gulf War veterans' illnesses: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004 Jul 20; 141(2):85-94.
Score: 0.003
-
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.
Score: 0.002
-
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants. Vaccine. 1998 Jan-Feb; 16(2-3):305-12.
Score: 0.002
-
Quantitative bacteriology of tonsils removed from children with tonsillitis hypertrophy and recurrent tonsillitis with and without hypertrophy. Ann Otol Rhinol Laryngol. 1995 Aug; 104(8):646-52.
Score: 0.002